Renaissance Technologies
CNTB

Renaissance Technologies’s Connect Biopharma Holdings CNTB Stock Holding History

Renaissance Technologies’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Sell
87,300
-33,400
-28% -$81K ﹤0.01% 2876
2026
Q1 		$316K Sell
120,700
-22,400
-16% -$58.4K ﹤0.01% 2776
2025
Q4 		$404K Sell
143,100
-15,100
-10% -$32.2K ﹤0.01% 2655
2025
Q3 		$239K Buy
158,200
+14,500
+10% +$25.7K ﹤0.01% 3087
2025
Q2 		$141K Buy
143,700
+28,900
+25% +$23K ﹤0.01% 3241
2025
Q1 		$63.1K Sell
114,800
-19,897
-15% -$18.4K ﹤0.01% 3264
2024
Q4 		$186K Sell
134,697
-40,803
-23% -$47K ﹤0.01% 3189
2024
Q3 		$253K Sell
175,500
-36,800
-17% -$44.9K ﹤0.01% 3045
2024
Q2 		$323K Sell
212,300
-27,600
-12% -$45.4K ﹤0.01% 2883
2024
Q1 		$417K Sell
239,900
-58,100
-19% -$70.6K ﹤0.01% 2938
2023
Q4 		$352K Buy
298,000
+201,000
+207% +$238K ﹤0.01% 2919
2023
Q3 		$79K Buy
97,000
+1,500
+2% +$1.37K ﹤0.01% 3295
2023
Q2 		$108K Buy
95,500
+6,400
+7% +$7.17K ﹤0.01% 3450
2023
Q1 		$89K Buy
89,100
+5,200
+6% +$5.67K ﹤0.01% 3523
2022
Q4 		$73K Buy
83,900
+600
+0.7% +$494 ﹤0.01% 3707
2022
Q3 		$107K Buy
83,300
+16,400
+25% +$19.7K ﹤0.01% 3575
2022
Q2 		$58K Buy
66,900
+43,400
+185% +$63.9K ﹤0.01% 3971
2022
Q1 		$71K Buy
23,500
+12,700
+118% +$53.6K ﹤0.01% 3850
2021
Q4 		$56K Buy
+10,800
New +$120K ﹤0.01% 3774

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

Renaissance Technologies's CNTB Position: Q2 2026 in Review

Renaissance Technologies reduced its Connect Biopharma Holdings (CNTB) stake by 28% in Q2 2026, selling an estimated $81K and leaving 87,300 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #2876.

Renaissance Technologies first reported a position in CNTB in Q4 2021 and has held it in 19 quarters since. The position peaked at $417K in Q1 2024. 56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • Renaissance Technologies held 87,300 shares of Connect Biopharma Holdings worth $208K as of Q2 2026.
  • Renaissance Technologies sold 33,400 Connect Biopharma Holdings shares in Q2 2026, an estimated $81K.
  • Connect Biopharma Holdings made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2876 holding.
  • Renaissance Technologies first reported a position in Connect Biopharma Holdings in Q4 2021 and has held it in 19 quarters since.
  • Renaissance Technologies's Connect Biopharma Holdings position peaked at $417K in Q1 2024.
  • 56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.